Biotech

Biotech Brittany Trang

STAT Plus: ‘Are we better off with the information?’: Experts spar over the benefits of liquid biopsy to catch cancer

Biotech Matthew Herper

STAT Plus: A new list ranks large pharmaceutical companies by research and development

Biotech Jason Mast

STAT Plus: Gene therapy has helped boys like Conner walk. Scientists are trying to keep it that way

Politics Rachel Cohrs

STAT Plus: New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Biotech Angus Chen

STAT Plus: CAR-T research is flourishing but is hampered by outdated precautions, experts say

Biotech Damian Garde

STAT Plus: For Eli Lilly’s head scientist, Alzheimer’s results cap a 25-year scientific quest

Biotech Jason Mast

STAT Plus: Now 18, the first child to ever receive CAR-T cancer therapy is ready for a new identity

Biotech Jason Mast

STAT Plus: Immunogen ovarian cancer drug shown to extend patients’ lives

Biotech Matthew Herper and Adam Feuerstein

STAT Plus: Eli Lilly’s Alzheimer’s therapy slowed patients’ rate of cognitive decline, data show

Biotech Adam Feuerstein and Damian Garde

STAT Plus: What to know about the upcoming readout of Eli Lilly’s experimental Alzheimer’s therapy

Biotech Jonathan Wosen

STAT Plus: Travere Therapeutics drug, approved for one rare and deadly kidney disease, fails in study of another

Biotech Jason Mast

STAT Plus: Astellas acquires Iveric Bio for $5.9B, entering competition to treat common cause of vision loss

Biotech Damian Garde

STAT Plus: Sam Waksal and Jeremy Levin plot ‘the turnaround story of the century’

Pharmalot Andrew Joseph

STAT Plus: Pharmalittle: Amgen ends two lupus programs; Illumina sequencers have security vulnerability

Biotech Matthew Herper

STAT Plus: FDA warns of security vulnerability in Illumina’s DNA sequencing machines

Pharmalot Andrew Joseph

STAT Plus: Pharmalittle: Lilly’s Mounjaro helped people lose 15.7% of body weight; Sanofi earnings boosted by Dupixent

Biotech Matthew Herper

STAT Plus: Eli Lilly’s Mounjaro succeeds in second weight loss study, paving way for FDA review

Biotech Allison DeAngelis

STAT Plus: Six months after launch, Bert Vogelstein’s latest blood testing startup gets acquired for $450 million

Politics Rachel Cohrs and Sarah Owermohle

STAT Plus: Pharma executives shower Bill Cassidy with campaign cash

Biotech Allison DeAngelis

STAT Plus: FDA approves Seres microbiome drug, as field advances

Biotech Damian Garde

STAT Plus: Alnylam’s ‘upstream’ Alzheimer’s treatment shows early promise

Exclusive Jason Mast

STAT Plus: Early findings in gene therapy death suggest CRISPR was not the cause

Politics John Wilkerson

STAT Plus: Another powerful congressional committee is ready to take on PBMs

Pharmalot Damian Garde

STAT Plus: Pharmalittle: EU unveils sweeping pharma reforms; new eye drug helps Roche beat the street

Biotech Allison DeAngelis

STAT Plus: RNA startup Orbital cinches $270 million investment

Politics John Wilkerson

STAT Plus: Medicare official insists drug price negotiation will consider value of drugs

Biotech Adam Feuerstein

STAT Plus: FDA approves new treatment from Biogen for rare form of ALS

Politics Rachel Cohrs

STAT Plus: Sens. Bernie Sanders, Bill Cassidy reach deal on PBM, generic reform

Pharmalot Damian Garde

STAT Plus: Pharmalittle: Novartis boosts its sales and profit outlook; Biogen trims its drug pipeline